Inclusion Criteria:  Pathologically confirmed invasive cervical cancer FIGO IB1-IIA Squamous cell cancer or HPV-related adenocarcinoma  Presence of tumour-related risk factors as follows:  tumour ≥4 cm OR tumour>2 cm <4 cm AND lymphovascular space invasion OR tumour >2 cm <4 cm AND tumour free distance <3 mm OR tumour >2 cm <4 cm AND deep stromal invasion (>2/3) No evidence of suspicious pelvic lymph nodes or distant metastases on imaging (by radiological subjective assessment before surgery and negative pelvic LN on final pathology) ECOG performance status 0-1 Deemed suitable and fit for radical surgery followed by adjuvant radiotherapy Negative pregnancy test (if applicable) Negative HIV test (only performed in high-risk countries or patients who have moved from those countries within the past 10 years)  Exclusion Criteria:  Adenosquamous cancer or adenocarcinoma unusual type (non-HPV related - such as: mucinous, clear cell, mesonephric) or other rare tumour types (those not listed in the inclusion criteria) Inconclusive primary site of disease Unequivocally positive lymph node by imaging (by radiological subjective assessment) FIGO <IB1 / >IIA Previous pelvic malignancy History of second primary cancer outside pelvis if ≤ 3 years complete clinical remission (CCR) Previous pelvic radiotherapy Neoadjuvant chemotherapy prior surgical treatment Low likelihood of patient compliance to the follow-up